19,600 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Acquired by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 19,600 shares of the company’s stock, valued at approximately $383,000.

Other institutional investors also recently bought and sold shares of the company. Rhumbline Advisers lifted its position in Privia Health Group by 1.3% during the 4th quarter. Rhumbline Advisers now owns 287,200 shares of the company’s stock worth $5,615,000 after acquiring an additional 3,658 shares during the period. Nordea Investment Management AB raised its holdings in Privia Health Group by 33.1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after purchasing an additional 86,910 shares in the last quarter. Franklin Resources Inc. lifted its position in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after purchasing an additional 28,480 shares during the period. Barclays PLC boosted its holdings in Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after purchasing an additional 14,641 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on PRVA shares. Piper Sandler lifted their price target on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. Canaccord Genuity Group boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Macquarie assumed coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 target price on the stock. JMP Securities set a $29.00 price objective on Privia Health Group in a research note on Friday, February 28th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a report on Friday, March 21st. One investment analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and a consensus target price of $26.67.

Insiders Place Their Bets

In related news, CFO David Mountcastle sold 5,630 shares of the stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 14.20% of the stock is owned by corporate insiders.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $21.97 on Friday. The firm has a market cap of $2.65 billion, a PE ratio of 219.72, a P/E/G ratio of 3.47 and a beta of 0.85. The firm has a 50 day simple moving average of $23.78 and a 200-day simple moving average of $21.29. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $26.04.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.